Published in Vopr Pitan on January 01, 2008
[To the 20th anniversary of the Chornobyl accident study of vitamin status and provision with micro- and macroelements of limited groups of people at different time periods since the accident at Chornobyl nuclear power plant]. Ukr Biokhim Zh (1999) (2006) 0.87
[Metabolism of B group vitamins in patients with insulin-dependent and non-insulin dependent forms of diabetes mellitus]. Vopr Med Khim (1994) 0.83
[Vitamin status of children with diabetes mellitus]. Vopr Med Khim (1994) 0.83
[Metabolism of riboflavin and B group vitamins functionally bound to it in insulin-dependent diabetes mellitus]. Vopr Med Khim (1994) 0.82
[Vitamin-antioxidant sufficiency of winter sports athletes]. Vopr Pitan (2013) 0.81
[The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity]. Vopr Pitan (2012) 0.81
[A comparison of fluorescent methods of determining the concentration of vitamin B2 in blood]. Vopr Pitan (1992) 0.80
Antioxidant status of rats receiving lycopene in different doses. Bull Exp Biol Med (2003) 0.79
[Effect of mycotoxins aflatoxin B1 and T-2 toxin on the vitamin D3 metabolism and binding of its hormonal form 1,25-dihydroxyvitamin D3 in rats]. Vopr Med Khim (1989) 0.78
[The clinical and experimental research of metabolic effects of shark liver oil]. Vopr Pitan (2007) 0.78
[Characteristics of calcium-phosphorus metabolism and vitamin D allowance in the Far North]. Vopr Pitan (1983) 0.78
[Clinical use of flavonoid enriched biologically active food supplements in patients with chronic atrophic gastritis in combination with chronic cholecystitis or bile ducts dyskinesia]. Vopr Pitan (2003) 0.78
[Influence of combined vitamin deficiency on unconditioned reflexes and learning in growing rats]. Vopr Pitan (2015) 0.77
[Effect of dietary fat on vitamin status of rats]. Vopr Pitan (2012) 0.77
[Assessment of efficiency of dietotherapy with addition of a vitamin-mineral complex in patients with diabetes mellitus type 2]. Vopr Pitan (2014) 0.77
[The effect of diet with the sour-milk product enriched with amaranth on parameters of antioxigen protection at patients with a cardiovascular pathology]. Vopr Pitan (2004) 0.77
[Effects of anti-atherosclerosis diet containing omega 3 fatty acids on the lipid spectrum of blood and cell membranes in patients with ischemic heart disease and essential hypertension]. Vopr Pitan (1991) 0.76
[Effect of diet including omega-3 polyunsaturated fatty acids on the status of T-cell immunity in patients with ischemic heart disease and hyperproteinemia]. Vopr Pitan (1997) 0.76
[Effect of irradiation on the vitamin status and spermatogenesis in rats]. Biull Eksp Biol Med (1997) 0.76
[Fat component in the diet and providing with fat-soluble vitamins]. Vopr Pitan (2014) 0.76
[Dietary effects of PUFA omega-3 on lipid peroxidation and antioxidant system in patients with IHD, hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.76
[Lipid peroxidation in patients with ischemic heart disease, hyperlipidemia and/or hypertension while polyunsaturated omega-3 fatty acids of plant and animal origin were in their diet]. Vopr Pitan (1997) 0.76
[Immune and metabolic effect of polyunsaturated fatty acids omega 3 in anti-atherosclerotic diet in the treatment of patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.76
[Effects of omega-3 polyunsaturated fatty acids on antioxidant capacity in rats]. Vopr Pitan (2013) 0.75
[Metabolism of 25-hydroxyvitamin D3 in the kidney and nuclear receptors of 1,25-dihydroxyvitamin D3 in small intestine mucosa of rats with vitamin B2 deficiency]. Vopr Med Khim (1988) 0.75
[The study of the clinical potency of antiatherogenic diet containing flavonoids in cardiovascular patients]. Vopr Pitan (2003) 0.75
The Health and Functioning ICF-60: development and psychometric properties. Clin Psychol Psychother (2014) 0.75
[The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia]. Vopr Pitan (2003) 0.75
[Effect of neonatal nutrition on the enzyme activity of liver lysosomes, adipocytes and thrombocytes in young and old rats]. Vopr Pitan (1986) 0.75
[Dietary fiber influence on vitamins assimilation in patients suffering from cardiovascular diseases and adiposity]. Vopr Pitan (2010) 0.75
[Effects of antiatherosclerosis diet including soy protein on the dynamics of clinical, biochemical and immunologic indicators in patients with ischemic heart disease and hypertension]. Vopr Pitan (1999) 0.75
[Definite of nutritional status in patients with metabolic syndrome with the use of modern methods of nutrimetabolomica]. Vopr Pitan (2010) 0.75
[Clinico-biochemical evaluation of the effectiveness of diet therapy in gastroenterologic patients]. Vopr Med Khim (1991) 0.75
[Clinical and metabolic effects of biological active food additives--phospholipids--in patients with cardiovascular diseases]. Vopr Pitan (1997) 0.75
[Study of fatty acid composition of cell membranes during the use of soya oil in diet therapy of patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75
[Current views of nutritional therapy]. Klin Med (Mosk) (2009) 0.75
[Study of the state of lipid peroxidation system: antioxidant protection during the use of soy oil in patients with ischemic heart disease and hypertension]. Vopr Pitan (2000) 0.75
[Comparative evaluation of hypolipidemic effects of omega-3 polyunsaturated acids and lipostabil]. Vopr Pitan (1996) 0.75
[The use of natural phytosterins for correction of abnormalities of lipid metabolism]. Kardiologiia (2011) 0.75
[Dynamics of the natural antibody level as affected by the biologically active food supplement "Vitol" in patients with hypertensive disease and obesity]. Vopr Pitan (1999) 0.75
[Use of fish oil enriched with carotenoids isolated from sea cucumbers in the diet therapy of patients with hypertension and ischemic heart disease]. Vopr Pitan (2003) 0.75
[Correction of mineral metabolism impairment with an allowance for seasonal fluctuations in patients with ischemic heart disease and hypertensive disease with overweight]. Vopr Pitan (2001) 0.75
[Effect of an anti-atherogenic diet, including soy protein products with various levels of phytoestrogens, on indicators of humoral immunity in patients with hypertension and ischemic heart disease]. Vopr Pitan (2002) 0.75
[Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates]. Klin Med (Mosk) (2003) 0.75
[Lipid peroxidation upon the use of omega-3 polyunsaturated fatty acids in the treatment of hypertension and ischemic heart disease]. Vopr Med Khim (1992) 0.75
[Vitamin status and bone mineral density at patients with adiposity and the cardiovascular pathology]. Vopr Pitan (2008) 0.75
[Immunoenzyme technique for detection of natural antibodies to bradykinin in cardiovascular diseases]. Klin Lab Diagn (2001) 0.75
[Effects of anti-atherosclerotic low-sodium diet on dynamics of natural antibodies to angiotensin II, bradykinin and vasopressin in blood of patients with hypertension and obesity]. Vopr Pitan (2001) 0.75
[Biologically active food supplements in comprehensive therapy of patients with ischemic heart disease and hypertension and the background of overweight]. Vopr Pitan (2000) 0.75
[Experience of phytosterols' application in dietetic cardiovascular diseases]. Vopr Pitan (2008) 0.75
[The assessment of clinical efficiency of the diet therapy in cardiosurgery patients]. Vopr Pitan (2007) 0.75
[Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension]. Vopr Pitan (1996) 0.75
[Effect of diet enriched with selenium on the psycho-emotional and adaptive capacity of patients with cardiovascular diseases and obesity]. Vopr Pitan (2012) 0.75
[Multilevel study of actual nutrition in the complex analysis of nutritial status of patients with obesity]. Vopr Pitan (2009) 0.75
[The system of multilevel diagnostics and corrections of nutrition status disorders in the patients with cardiovascular diseases]. Vopr Pitan (2009) 0.75
[Efficacy of the use of a sour milk product enriched with phytosterols in diet therapy of patients with cardiovascular diseases]. Kardiologiia (2008) 0.75
[Change of natural antibody levels in patients with cardiovascular diseases by the use of anti-atherogenic diets with processed soy product foods]. Vopr Pitan (2002) 0.75
[Clinical efficiency of using laminaria jam enriched with selenium]. Vopr Pitan (2009) 0.75
[Soybean proteins in correction of coronary risk factors in patients with cardiovascular diseases]. Vopr Pitan (2002) 0.75
[Anti-atherosclerotic properties of some components of food (a clinico-experimental study)]. Vopr Pitan (1990) 0.75
[Dietary correction of nutrition status in patients with metabolic syndrome]. Vopr Pitan (2009) 0.75
[The effect of diets containing omega-3 polyunsaturated fatty acids on biochemical indicators and the fatty acid composition of the cell membranes in patients with ischemic heart disease and hereditary hyperlipidemia]. Vopr Med Khim (1992) 0.75
[Analysis of modern concepts concerning the role of processed soybean products in diet therapy of patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75
[Use of phytoestrogens in medicine]. Vopr Pitan (2003) 0.75
[Peculiarity mineralization of osteous tissue of patients wits cardiovascular and gastroenteric pathologic and provision with vitamins and calcium]. Vopr Pitan (2008) 0.75
[Marine fish oil in the prevention and treatment of cardiovascular diseases]. Vestn Ross Akad Med Nauk (1996) 0.75
[Activity of phospholipases A in the adipose tissue and adipocytes in obesity and ischemic heart disease]. Ter Arkh (1982) 0.75
[The study of polymorphism rs9939609 FTO gene in patients with overweight and obesity]. Vopr Pitan (2011) 0.75
[Homocysteine as a coronary risk factor]. Vopr Pitan (2003) 0.75
[The study of FTO rs9939609-gene polymorphism in the Sverdlovsk Region]. Vopr Pitan (2012) 0.75
[Effects of biologically active supplements on the antioxidant and vitamin status of patients with hypertension and ischemic heart disease]. Vopr Pitan (2001) 0.75
[Effects of diet containing polyunsaturated fatty acids omega-3 and different doses of vitamin E on the activity of lipid peroxidation in patients with hypertension]. Vopr Pitan (1995) 0.75
[Clinico-metabolic effects of fish oil in patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.75
[Effect of clofibrate on the enzyme activity of liver and adipose tissue lysosomes in the rat in the presence of an unbalanced fatty component in the diet]. Patol Fiziol Eksp Ter (1984) 0.75
[Cholesterol metabolism in patients with ischemic heart disease with varying supplies of omega-3 polyunsaturated fatty acids]. Vopr Med Khim (1995) 0.75
[Peculiarities of vitamin status in men and women with cardiovascular disease and obesity]. Vopr Pitan (2012) 0.75
[The study of soy isoflavone metabolism in patients with cardiovascular diseases]. Vopr Pitan (2002) 0.75
[Influence of chitosan on clinical-biochemical rates and protein metabolism of patients with cardiovascular diseases]. Vopr Pitan (2008) 0.75
[Clinical-metabolic evaluation of the effectiveness of the olive oil use in patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75